<![CDATA[81]]>81
Så kom der endnu et fase 3 forsøg i 3.line CLL mod ofatumumab:

Safety and Efficacy of Dinaciclib or Ofatumumab in Participants With Refractory Chronic Lymphocytic Leukemia (P07714) This study is not yet open for participant recruitment. Verified April 2012 by Schering-Plough

]]>https://dev.proinvestor.com/forum/topic/448411/81RSS for NodeSat, 20 Jun 2026 02:19:36 GMTWed, 18 Apr 2012 16:30:33 GMT60